wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33420907-2BA76732-10E0-4D9B-8917-DD09EAEDF69B
Q33420907-2BA76732-10E0-4D9B-8917-DD09EAEDF69B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33420907-2BA76732-10E0-4D9B-8917-DD09EAEDF69B
First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy.
P2860
Q33420907-2BA76732-10E0-4D9B-8917-DD09EAEDF69B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33420907-2BA76732-10E0-4D9B-8917-DD09EAEDF69B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e5fd7c5fa03d96a365de3cad26dd5b784e9f57db
P2860
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial.